P591: PRELIMINARY RESULTS OF A PHASE I STUDY OF CLIFUTINIB, A HIGHLY SELECTIVE, POTENT ORAL FLT-3 INHIBITOR, IN PATINETS WITH FLT3-MUTATED RELAPSED OR REFRACTORY ACUTE MYELOID LEUK... by W. Yu, X. Wei, Z. Ge, Y. Li, Z. Jiang, L. Yang, L. Lin, Y. Yao, X. Deng, X. Du, Y. Li, T. Chen, X. Feng, J. Zhou, M. Hou, R. Fu, J. Lan, X. Hu, S. Huang, J. Wang, X. Du, H. Yang, H. Yang, H. Wang, L. Zheng, Z. Wang, B. Liu, N. Kang, Y. Zhuang, Y. Zhang, J. Jin

Get full text